These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1719444)
1. Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Elliott PJ; Mason GS; Stephens-Smith M; Hagan RM Neuropeptides; 1991 Jun; 19(2):119-26. PubMed ID: 1719444 [TBL] [Abstract][Full Text] [Related]
2. Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function. Hagan RM; Ireland SJ; Jordan CC; Beresford IJ; Deal MJ; Ward P Neuropeptides; 1991 Jun; 19(2):127-35. PubMed ID: 1719445 [TBL] [Abstract][Full Text] [Related]
3. Neurokinin agonists differentially affect A9 and A10 dopamine cells in the rat. Overton P; Elliott PJ; Hagan RM; Clark D Eur J Pharmacol; 1992 Mar; 213(1):165-6. PubMed ID: 1379929 [TBL] [Abstract][Full Text] [Related]
4. Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens. Hall JM; Morton IK Br J Pharmacol; 1991 Feb; 102(2):511-7. PubMed ID: 1707714 [TBL] [Abstract][Full Text] [Related]
5. Neurokinin receptors in the rabbit iris sphincter characterised by novel agonist ligands. Hall JM; Mitchell D; Morton IK Eur J Pharmacol; 1991 Jun; 199(1):9-14. PubMed ID: 1716575 [TBL] [Abstract][Full Text] [Related]
6. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032 [TBL] [Abstract][Full Text] [Related]
7. Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat. Mason GS; Elliott PJ Neuropharmacology; 1992 Aug; 31(8):757-60. PubMed ID: 1382245 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the rat mesolimbic dopamine pathway by neurokinins. Elliott PJ; Mason GS; Graham EA; Turpin MP; Hagan RM Behav Brain Res; 1992 Oct; 51(1):77-82. PubMed ID: 1282818 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Couture R; Laneuville O; Guimond C; Drapeau G; Regoli D Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 340(5):547-57. PubMed ID: 2482449 [TBL] [Abstract][Full Text] [Related]
10. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907 [TBL] [Abstract][Full Text] [Related]
11. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum. Gauchy C; Desban M; Glowinski J; Kemel ML Neuroscience; 1996 Aug; 73(4):929-39. PubMed ID: 8809812 [TBL] [Abstract][Full Text] [Related]
12. Further studies on the effects of selective neurokinin agonists upon the activation of micturition reflex in rats. Evidence for a dual NK-1 receptor mediated excitatory and inhibitory activity. Palea S; Dalforno G; Gaviraghi G; Hagan RM; Trist DG; Pietra C Neuropeptides; 1993 May; 24(5):285-91. PubMed ID: 7687043 [TBL] [Abstract][Full Text] [Related]
14. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat. Humpel C; Saria A Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197 [TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs. Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090 [TBL] [Abstract][Full Text] [Related]
16. Modulation of excitatory amino acid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord. Cumberbatch MJ; Chizh BA; Headley PM Br J Pharmacol; 1995 Jul; 115(6):1005-12. PubMed ID: 7582496 [TBL] [Abstract][Full Text] [Related]
17. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments. Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682 [TBL] [Abstract][Full Text] [Related]
19. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors? Tauer U; Zhao Y; Hunt SP; Culman J Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977 [TBL] [Abstract][Full Text] [Related]
20. Tachykinin NK-1 and NK-3 selective agonists induce analgesia in the formalin test for tonic pain following intra-VTA or intra-accumbens microinfusions. Altier N; Stewart J Behav Brain Res; 1997 Dec; 89(1-2):151-65. PubMed ID: 9475623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]